Market · AI in practice
Rivio closes Series A with agents on the hospital revenue cycle
In a November 4, 2026 release, Rivio reports a R$180 million extension of its Series A and a valuation above R$1 billion; the model pairs AI agents with specialized operations and outcome-linked fees.
What the sources report
On November 4, 2026, Rivio said it finalized the extension of its Series A with a R$180 million investment, led by Valor Capital Group, with Monashees, Positive Ventures and APL. With the deal, the company reaches a valuation above R$1 billion, just over a year after its 2025 founding.
In the hospital revenue cycle, AI agents analyze information, support bill review and flag inconsistencies that create lost billing or delayed collections. Healthcare specialists run the operation alongside the agents. Rivio takes on process execution with the hospital and ties its compensation to results. It already operates in 13 hospital groups; public names include Einstein, Sírio-Libanês and Oswaldo Cruz.
Adriano's reading
The thesis: agents gain traction when the vendor carries the end-to-end process and the contract ties payment to outcome. For anyone buying or selling AI in regulated back offices, I would look first at that responsibility structure — execution, human exception handling and cash metrics — before debating the model alone.